From professional translators, enterprises, web pages and freely available translation repositories.
fludarabine
fludarabin
Last Update: 2016-10-20
Usage Frequency: 5
Quality:
Reference:
busilvex in combination with fludarabine
busilvex fludarainnal kombinálva
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
patients refractory to fludarabine and alemtuzumab
fludarabin- és alemtuzumab-refrakter betegek
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
busilvex in combination with fludarabine (fb)
busilvex fludarabinnal kombinálva (fb)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
busulfan fresenius kabi in combination with fludarabine
busulfan fresenius kabi fludarainnal kombinálva
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
71 2192 100 100 alkylating agents 100 34 100 fludarabine
rai stádium iii/iv b tünetek76 4272 3171 21 korábbi terápiák (%)alkiláló hatóanyagok fludarabin100 100
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
busilvex in combination with fludarabine (fb) in adults
busilvex fludarabinnal kombinálva (fb) felnőtteknél
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
in adults busilvex is used in combination with cyclophosphamide or fludarabine.
felnőtteknél a busilvex-et ciklofoszfamiddal vagy fludarabinnal kombinálva alkalmazzák.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
pts who had failed to respond or relapsed following treatment with fludarabine
nem reagáló, vagy a kezelést követően
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
b-cll pts who had received an alkylating agent and had failed fludarabine
alkiláló hatóanyaggal kezelt és fludarabinra nem reagáló b-cll betegek
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
the main study included 93 patients in whom previous treatment with fludarabine had stopped working.
a f vizsgálatban 93 beteg vett részt, akiknél a fludarabin-kezelés már nem volt eredményes.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
arzerra is indicated for the treatment of cll in patients who are refractory to fludarabine and alemtuzumab.
az arzerra olyan cll-ben szenvedő betegek kezelésére javallott, akik refrakterek fludarabin- és alemtuzumab-kezelésre.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
alkylating agents fludarabine number of prior regimens (range) initial dosing regimen
alkiláló hatóanyagok fludarabin
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
co-administration with mabthera did not appear to have an effect on the pharmacokinetics of fludarabine or cyclophosphamide.
a mabthera együttadása nem volt hatással a fludarabin vagy ciklofoszfamid farmakokinetikájára.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
received an alkylating respond or relapsed relapsed following agent and had failed following treatment treatment with fludarabine with fludarabine conventional chemotherapy
kezelést követen kezelésre nem nem reagáló b-cll relapsust mutató b -reagáló vagy a betegek cll betegek (plusz kezelést követen egy pll beteg) relapsust mutató b -cll betegek
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
b-cll (plus a pll) pts who had failed to respond or relapsed following treatment with fludarabine
fludarabin kezelésre nem reagáló, vagy a kezelést követően relapsust mutató b- cll betegek (plusz egy pll beteg)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
in cll patients, co-administration with mabthera did not appear to have an effect on the pharmacokinetics of fludarabine or cyclophosphamide.
a cll-ben szenvedő betegeknél a mabthera együttadása nem volt hatással a fludarabin vagy ciklofoszfamid farmakokinetikájára.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Reference:
mabcampath is used in patients for whom treatment combinations including fludarabine (another medicine used in leukaemia) are not appropriate.
a mabcampath-et olyan betegeknél alkalmazzák, akiknél a kombinált kezelések, beleértve a fludarabint (egy másik, leukémia esetén alkalmazott gyógyszer) nem megfelelek.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
hence the risk of haematological toxicity may be increased when zevalin is administered shortly (< 4 months) after fludarabine containing regimens.
ezek alapján a hematológiás toxicitás kockázata fokozott, ha a zevalint röviddel (< 4 hónap) a fludarabint tartalmazó kezelés után alkalmazzák.
Last Update: 2012-04-12
Usage Frequency: 3
Quality:
Reference:
Warning: Contains invisible HTML formatting
if you receive zevalin 4 months or less after another chemotherapy which included the medicine fludarabine, you may have a higher risk to develop a reduced number of blood cells.
ha másik, a fludarabin- t is tartalmazó kemoterápiás kezelés után kevesebb, mint 4 hónappal kap zevalint, fokozott a veszélye, hogy a vörösvértestek száma lecsökken.
Last Update: 2012-04-12
Usage Frequency: 3
Quality:
Reference: